Caplin Point Laboratories share price
NSE: CAPLIPOINT · Biotechnology & Drugs
₹2,364.6 +1.21%
Data as of 2026-11-03 (NSE close)
1-year price chart
Key ratios
Market cap
₹17,752 Cr
P/E
30.00x
P/B
5.04x
ROE
21.2%
ROCE
n/a
Debt / Equity
0
Dividend yield
0.34%
52W high / low
₹2,990 / ₹1,500.3
Latest Caplin Point Laboratories news
Caplin Steriles Receives USFDA Final Approval for Desmopressin Acetate Injection · 2026-03-02
Biotechnology & Drugs peers
AI analysis
Sign up free to see the full analysis
Quantsgrow scorecard
Sign up free to see the full analysis